Cargando…
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that possess mutations associated with increased transmission and antibody escape have arisen over the course of the current pandemic. Although the current vaccines have largely been effective against past variants, the n...
Autores principales: | Sievers, Benjamin L., Chakraborty, Saborni, Xue, Yong, Gelbart, Terri, Gonzalez, Joseph C., Cassidy, Arianna G., Golan, Yarden, Prahl, Mary, Gaw, Stephanie L., Arunachalam, Prabhu S., Blish, Catherine A., Boyd, Scott D., Davis, Mark M., Jagannathan, Prasanna, Nadeau, Kari C., Pulendran, Bali, Singh, Upinder, Scheuermann, Richard H., Frieman, Matthew B., Vashee, Sanjay, Wang, Taia T., Tan, Gene S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891085/ https://www.ncbi.nlm.nih.gov/pubmed/35025672 http://dx.doi.org/10.1126/scitranslmed.abn7842 |
Ejemplares similares
-
A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022) -
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
por: Chakraborty, Saborni, et al.
Publicado: (2022) -
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
por: Hu, Zicheng, et al.
Publicado: (2022) -
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
por: Hu, Zicheng, et al.
Publicado: (2022) -
Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk
por: Golan, Yarden, et al.
Publicado: (2021)